CR20220619A - Ácido nucleico codón-optimizado que codifica la proteína smn1 y su uso - Google Patents

Ácido nucleico codón-optimizado que codifica la proteína smn1 y su uso

Info

Publication number
CR20220619A
CR20220619A CR20220619A CR20220619A CR20220619A CR 20220619 A CR20220619 A CR 20220619A CR 20220619 A CR20220619 A CR 20220619A CR 20220619 A CR20220619 A CR 20220619A CR 20220619 A CR20220619 A CR 20220619A
Authority
CR
Costa Rica
Prior art keywords
nucleic acid
acid encoding
codon
optimized nucleic
protein
Prior art date
Application number
CR20220619A
Other languages
English (en)
Inventor
Maria Andreevna Lomunova
Dmitry Valentinovich Morozov
Pavel Mikhailovich Gershovich
Tatiana Evgenievna Shugaeva
Margarita Aleksandrovna Shkliaeva
Dmitriy Aleksandrovich Madera
Anna Sergeevna Veselova
Original Assignee
Biocad Joint Stock Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocad Joint Stock Co filed Critical Biocad Joint Stock Co
Publication of CR20220619A publication Critical patent/CR20220619A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4707—Muscular dystrophy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente solicitud se refiere a los campos de la genética, la terapia génica y la biología molecular. Más específicamente, la presente invención se refiere a un ácido nucleico codón-optimizado aislado que codifica la proteína SMN1 (proteína de la neurona motora de supervivencia), un casete de expresión y un vector basado en el mismo, así como un virus recombinante basado en AAV9 (virus adenoasociado de serotipo 9) para aumentar la expresión del gen SMN1 en células diana, y su uso.<br /> <br />
CR20220619A 2020-06-02 2021-06-02 Ácido nucleico codón-optimizado que codifica la proteína smn1 y su uso CR20220619A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2020118148A RU2742837C1 (ru) 2020-06-02 2020-06-02 Кодон-оптимизированная нуклеиновая кислота, которая кодирует белок SMN1, и ее применение
PCT/RU2021/000238 WO2021246909A1 (ru) 2020-06-02 2021-06-02 Кодон-оптимизированная нуклеиновая кислота, кодирующая белок smn1

Publications (1)

Publication Number Publication Date
CR20220619A true CR20220619A (es) 2023-06-14

Family

ID=74665909

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20220619A CR20220619A (es) 2020-06-02 2021-06-02 Ácido nucleico codón-optimizado que codifica la proteína smn1 y su uso

Country Status (21)

Country Link
US (1) US20230212609A1 (es)
EP (1) EP4159863A1 (es)
JP (1) JP2023529855A (es)
KR (1) KR20230019162A (es)
CN (1) CN116234914A (es)
AR (1) AR122500A1 (es)
AU (1) AU2021282898A1 (es)
BR (1) BR112022024708A2 (es)
CA (1) CA3181288A1 (es)
CL (1) CL2022003428A1 (es)
CO (1) CO2022017334A2 (es)
CR (1) CR20220619A (es)
EC (1) ECSP22092206A (es)
IL (1) IL298772A (es)
MA (1) MA58655B1 (es)
MX (1) MX2022015231A (es)
PE (1) PE20240079A1 (es)
RU (1) RU2742837C1 (es)
TW (1) TW202214862A (es)
UY (1) UY39245A (es)
WO (1) WO2021246909A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117210457A (zh) * 2022-06-10 2023-12-12 拜奥卡德联合股份公司 具有启动子活性的核酸及其用途
WO2023246734A1 (en) * 2022-06-21 2023-12-28 Skyline Therapeutics (Shanghai) Co., Ltd. Recombinant aav for the gene therapy of sma disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
DE3431140A1 (de) 1984-08-24 1986-03-06 Behringwerke Ag, 3550 Marburg Enhancer fuer eukaryotische expressionssysteme
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
RU2312896C2 (ru) * 2001-09-20 2007-12-20 Глаксо Груп Лимитед Последовательность нуклеиновой кислоты, кодирующая белок gag вич-1, способ получения указанной последовательности, вектор, содержащий ее, белок, кодируемый ею, фармацевтическая композиция и их применение для профилактики и/или лечения вич-инфекции и спида
JP7082050B2 (ja) * 2015-12-14 2022-06-07 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 脊髄性筋萎縮症の処置において有用なアデノ－関連ウイルスベクター

Also Published As

Publication number Publication date
US20230212609A1 (en) 2023-07-06
JP2023529855A (ja) 2023-07-12
AU2021282898A1 (en) 2023-02-02
EP4159863A1 (en) 2023-04-05
AR122500A1 (es) 2022-09-14
ECSP22092206A (es) 2023-01-31
CL2022003428A1 (es) 2023-06-09
MX2022015231A (es) 2023-02-09
RU2742837C1 (ru) 2021-02-11
CN116234914A (zh) 2023-06-06
BR112022024708A2 (pt) 2023-04-11
IL298772A (en) 2023-02-01
KR20230019162A (ko) 2023-02-07
MA58655A1 (fr) 2023-06-28
WO2021246909A1 (ru) 2021-12-09
CA3181288A1 (en) 2021-12-09
CO2022017334A2 (es) 2023-04-17
PE20240079A1 (es) 2024-01-16
MA58655B1 (fr) 2023-12-29
TW202214862A (zh) 2022-04-16
UY39245A (es) 2021-12-31

Similar Documents

Publication Publication Date Title
CR20220619A (es) Ácido nucleico codón-optimizado que codifica la proteína smn1 y su uso
TN2020000187A1 (en) Hybrid recombinant adeno-associated virus serotype between aav9 and aavrh74 with reduced liver tropism
Shchedrina et al. Identification and characterization of a selenoprotein family containing a diselenide bond in a redox motif
JP2021112211A5 (es)
US11674128B2 (en) Engineering of a minimal SaCas9 CRISPR/Cas system for gene editing and transcriptional regulation optimized by enhanced guide RNA
Wang et al. Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidate
Flotte et al. Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway
Yang et al. Enhanced antitumor activity and selectivity of lactoferrin‐derived peptides
MX2022002184A (es) Proteina vp1 modificada aislada de la capside del virus adeno-asociado de serotipo 5 (aav5), capside y vector basado en la misma.
CR20230363A (es) Efecto sinérgico de smn1 y mir-23a en el tratamiento de la atrofia muscular espinal
MX2022010388A (es) Polipéptidos de la cápside y vectores de virus adenoasociado.
CR20230429A (es) Ácido nucleico optimizado por codones que codifica la proteína del factor de coagulación IX, y su uso
Klimina et al. Bacterial toxin–antitoxin systems: Properties, functional significance, and possibility of use
JP2020127419A5 (es)
BR112021002231A2 (pt) novo ativador de transcrição
WO2022226183A3 (en) Optimized ap4m1 polynucleotides and expression cassettes and their use
WO2020132115A8 (en) Methods and compositions for treating glycogen storage diseases
BR112022010095A2 (pt) Proteínas gpcr de opsina quimérica
Dahl et al. Small acid-soluble proteins with intrinsic disorder are required for UV resistance in Myxococcus xanthus spores
BRPI0415296A (pt) cdna modificado para os nìveis de expressão elevados do fator viii e seus derivados
Ivanova et al. Genome Sequence Data of Lactobacillus ruminis ICIS-540, Isolated from the Intestine of a Healthy Woman
WO2022241215A3 (en) Adenoviral helper plasmid
WO2023173072A1 (en) Systems and methods for genetic modulation to treat liver disease
Vafina et al. A one-step protocol for chromatographic purification of non-recombinant exogenous bacterial enzyme: nuclease of Serratia marcescens
Li et al. CodonBert large language model for mRNA vaccines